Monica T Hinds Selected Research

AB023

12/2021	The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.
1/2019	Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica T Hinds Research Topics

Disease

14	Thrombosis (Thrombus) 01/2022 - 01/2014
5	Hyperplasia 01/2020 - 01/2012
4	Hemorrhage 06/2020 - 03/2016
3	Atherosclerosis 06/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 02/2010
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2019
1	Pain (Aches) 01/2022
1	Chronic Pain 01/2022
1	Anemia 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021
1	Myocardial Infarction 01/2021
1	Stroke (Strokes) 01/2021
1	COVID-19 05/2020
1	Sepsis (Septicemia) 05/2020
1	Pneumonia (Pneumonitis) 05/2020
1	Pathologic Processes 10/2019
1	Leukemia 10/2019
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Neoplasms (Cancer) 10/2019
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Plague (Bubonic Plague) 01/2019
1	Venous Thromboembolism 01/2019
1	Reperfusion Injury 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016
1	Bruton type agammaglobulinemia 03/2016
1	Hyperglycemia 01/2013
1	Wounds and Injuries (Trauma) 10/2012

Drug/Important Bio-Agent (IBA)

4	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022 - 01/2018
4	Biocompatible Materials (Biomaterials)IBA 04/2020 - 01/2012
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 01/2020
3	FibrinIBA 01/2020 - 01/2019
2	ibrutinibIBA 06/2022 - 03/2016
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 10/2019
2	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 01/2014
2	AB023IBA 12/2021 - 01/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 11/2018
2	Hemostatics (Antihemorrhagics)IBA 06/2020 - 10/2019
2	Polytetrafluoroethylene (Teflon)FDA Link 04/2020 - 01/2020
1	Medical MarijuanaIBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022
1	Erythropoietin FDA Link 12/2021
1	IronIBA 12/2021
1	Thrombin FDA Link 12/2021
1	PrekallikreinIBA 01/2021
1	Kininogens (Kininogen)IBA 01/2021
1	cadherin 5IBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	AntibodiesIBA 01/2021
1	ISIS 416858IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 06/2020
1	CytokinesIBA 05/2020
1	HydrogelsIBA 04/2020
1	trimetaphosphoric acid (sodium trimetaphosphate)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	CollagenIBA 01/2020
1	EnzymesIBA 01/2020
1	Protein CIBA 01/2020
1	fucoidanIBA 01/2020
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 10/2019
1	Platelet Factor 4IBA 10/2019
1	Thrombopoietin (c-mpl Ligand)IBA 10/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	SolutionsIBA 01/2019
1	Clopidogrel (Plavix)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Phospholipases (Phospholipase)IBA 03/2016
1	platelet membrane glycoprotein VIIBA 03/2016
1	CarbodiimidesIBA 03/2015
1	ThrombomodulinIBA 01/2014
1	Cyclin D1IBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Fibronectins (Fibronectin)IBA 10/2012
1	Collagen Type IV (Type IV Collagen)IBA 10/2012
1	Laminin (Merosin)IBA 10/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010
1	E-SelectinIBA 02/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
1	Renal Dialysis (Hemodialysis) 12/2021
1	Euthanasia (Mercy Killing) 10/2019
1	Stents 10/2017